LabArchives

Dotmatics' LabArchives ELN Solution Achieves "In Process" Designation from FedRAMP, Sponsored by National Institutes of Health

Retrieved on: 
Thursday, April 4, 2024
Dotmatics, NCI, Government, Organization, Schedule, NCATS, Documentation, Environment, Federation, Research, National Cancer Institute, News, Management, ELN, LabArchives, NIH, NIST, Risk assessment, National archives, Inventory, Confidentiality, FedRAMP, Bangladesh Technical Education Board, Calendar, ISO, Data management, Medical device

BOSTON, April 4, 2024 /PRNewswire/ -- Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced that its LabArchives for Government solution has achieved the "In-Process" designation granted by the Federal Risk and Authorization Management Program (FedRAMP®). LabArchives' FedRAMP application is sponsored by the National Cancer Institute of the National Institutes of Health (NIH). LabArchives lets organizations securely organize, search, and share data in a powerful electronic lab notebook (ELN) that supports scientific research and breakthroughs. The news is a critical milestone on the path to attaining FedRAMP authorization. LabArchives for Government is now listed on the FedRAMP Marketplace and will operate as a trusted partner to federal agencies upon authorization.

Key Points: 
  • LabArchives' FedRAMP application is sponsored by the National Cancer Institute of the National Institutes of Health (NIH).
  • LabArchives lets organizations securely organize, search, and share data in a powerful electronic lab notebook (ELN) that supports scientific research and breakthroughs.
  • LabArchives for Government is now listed on the FedRAMP Marketplace and will operate as a trusted partner to federal agencies upon authorization.
  • FedRAMP is the U.S. government program that provides a safe, standardized approach to security and risk assessment for cloud technologies.

Dotmatics Launches Small Molecule Drug Discovery Solution Helping Researchers Accelerate Life-Improving Therapies

Retrieved on: 
Monday, July 18, 2022
Molecule, Cheminformatics, Research, LabArchives, Biology, Discovery, Patient, Database, Gaps, Solution, Pharmacy, View, Drug discovery, Insight Partners, Technology, Flow cytometry, Ownership, QC, Workflow, Chemistry, DMPK, GraphPad Software, Organization, CRO, Efficiency, Congressional Budget Office, FAIR, SAR, Data management, Fine chemical, Pharmaceutical industry, Dotmatics, Charles River Laboratories

The solution helps companies innovate more easily by leveraging best practices derived from the company's 15+ years of experience supporting small molecule drug discovery.

Key Points: 
  • The solution helps companies innovate more easily by leveraging best practices derived from the company's 15+ years of experience supporting small molecule drug discovery.
  • The Small Molecule Drug Discovery Solution promotes greater collaboration and productivity among research teams, reduces operational inefficiencies, and speeds the process of taking data from insights to decisions.
  • In May, Dotmatics introduced its Biology Solution for Antibody Discovery , which combines Dotmatics' enterprise scientific platform with advanced applications software used routinely in antibody discovery laboratories.
  • The Dotmatics Small Molecule Drug Discovery Solution incorporates FAIR data practices and provides a uniquely broad and deep solution from hit discovery through lead optimization to progress into animal trials and translational medicine.

Protein Metrics receives Several US Patents, Strengthening the Company's Intellectual Property Position

Retrieved on: 
Tuesday, June 21, 2022
Name, Insight Partners, GraphPad Software, Patent, Observation, CEO, Data compression, Efficiency, Biotechnology, San Francisco Bay Area, Mass spectrometry, Dotmatics, LabArchives, Software, Doctor of Philosophy, Thought, Organization, Fine chemical, Management

CUPERTINO, Calif., June 21, 2022 /PRNewswire-PRWeb/ -- Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software and part of the Dotmatics family of scientific R&D software, announced today the granting of three new US patents. The patent names and numbers are entitled: "Interactive analysis of mass spectrometry data (US #11,289,317)", "Data compression for multidimensional time series data US 11,276,204)", and "Intact mass reconstruction from peptide level data and facilitated comparison with experimental intact observation. (US 11,346,844 B2)"

Key Points: 
  • (US 11,346,844 B2)"
    This adds to the growing corpus of patents and underscores Protein Metrics' commitment to innovation and its position at the forefront of the field of protein analysis.
  • In December, Protein Metrics was acquired by Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making.
  • Protein Metrics supports hundreds of organizations worldwide with Byos and Byosphere Enterprise Platform for protein characterization.
  • Learn more about Dotmatics, its platform, and applications including GraphPad Prism, Geneious, SnapGene, Protein Metrics, and LabArchives at https://dotmatics.com .

Dotmatics Strengthens Leadership Team as it Continues to Invest in Organization Capabilities and Accelerate Growth

Retrieved on: 
Monday, June 6, 2022
Research, Technology, Chemicals, Plastics, Software, Manufacturing, Biotechnology, Pharmaceutical, Health, Data Management, Science, People, Board, Dropbox, Goal, International relations, HR, Google, COVID, General counsel, Research, Accenture, IPO, Corporation, CEO, Love, ARR, Organization, Solution, LabArchives, Technology, Data management, Columbia University, Insight Partners, Tufts University, Culture, Efficiency, Master, Boston University, GraphPad Software, Software as a service, Cancer, Master of International Affairs, Management, Cvent, Dotmatics

The appointments further bolster the companys executive team as the company extends the reach of its research and data solutions globally.

Key Points: 
  • The appointments further bolster the companys executive team as the company extends the reach of its research and data solutions globally.
  • Dotmatics is helping scientists to accelerate discoveries that make the world a healthier, cleaner and safer place to live.
  • We are adding Larry and Neil at a significant time in our companys growth, said Thomas Swalla, CEO of Dotmatics.
  • Learn more about Dotmatics, its platform, and applications including GraphPad Prism, Geneious, SnapGene, Protein Metrics, and LabArchives at https://dotmatics.com .

Dotmatics Biology Solution for Antibody Discovery Streamlines Data Collection and Workflows to Accelerate Antibody Research and Therapies

Retrieved on: 
Tuesday, May 3, 2022
Technology, Research, Clinical Trials, Software, Biotechnology, Health, Pharmaceutical, Data Management, Science, Insight Partners, Data management, Love, Chemistry, CLC bio, FAIR, Patient, Digital Solutions, LabArchives, Organization, Research report, Â, Workflow, Efficiency, Science, Conference, Research, Biology, Growth, GraphPad Software, Medical device, Fine chemical, Vaccine, Dotmatics

The antibody workflow combines Dotmatics enterprise scientific platform with advanced applications software used routinely in antibody discovery laboratories including Geneious , SnapGene , and GraphPad Prism .

Key Points: 
  • The antibody workflow combines Dotmatics enterprise scientific platform with advanced applications software used routinely in antibody discovery laboratories including Geneious , SnapGene , and GraphPad Prism .
  • The fully integrated solution will streamline data collection and processing of the antibody discovery workflow, facilitating a pathway to more effective and efficient discovery, and accelerating progress towards potentially life-changing therapies for patients.
  • The launch of the Dotmatics Biology Solution for Antibody Discovery is the industrys first true end-to-end solution for antibody workflows and represents a huge step forward for innovation in antibody discovery, said Mike McKee, president of Dotmatics.
  • Whether its R&D for biology or chemistry or formulations, Dotmatics helps scientists and their organizations harmonize data science with the science data.

Flow Cytometry Services Market Expected to Reach $ 1.5 Billion by 2030 - InsightAce Analytic Pvt. Ltd.

Retrieved on: 
Wednesday, March 2, 2022
Investment, Multiple myeloma, Government, LLC, KCAS, Acquisition, HIV, Cell, Diagnosis, Flow cytometry, Leukemia, NeoGenomics, Awareness, Solution, Drug development, US, Company, Cancer, Lymphoma, Transport, Becton, Infection, Becton, Dickinson and Company headquarters, BD, Science, GraphPad Software, Efficiency, Laboratory, Research, LabArchives, Charles River Laboratories, Bio-Rad Laboratories, Data analysis, Protein, CAGR, Glossary of biology, AIDS, Antibody, Fine chemical, Medical imaging, Unilab, Fluorescence

According to the latest research by InsightAce Analytic, the global Flow Cytometry Services market is valued at US$ 876.33 Million in 2021, and it is expected to reach US$ 1,501.02 Million by 2030, with a CAGR of 6.21% during the forecast period of 2022-2030.

Key Points: 
  • According to the latest research by InsightAce Analytic, the global Flow Cytometry Services market is valued at US$ 876.33 Million in 2021, and it is expected to reach US$ 1,501.02 Million by 2030, with a CAGR of 6.21% during the forecast period of 2022-2030.
  • Flow cytometry is an effective laboratory technique used to analyze the cell population in heterogenous suspension based on their physical and fluorescence characteristics.
  • Flow Cytometry services consist of specimen processing, experimental design, acquisition and data analysis to strengthen biotech, pharmaceutical companies and researchers in drug development.
  • Curious about Report Details @ Request for ToC/Proposal: https://www.insightaceanalytic.com/report/global-flow-cytometry-services...
    Global Flow Cytometry Services Market, by Accreditation Types, 2019-2030 (Value US$ Mn)
    Global Flow Cytometry Services Market, by Services Types, 2019-2030 (Value US$ Mn)

Flow Cytometry Services Market Expected to Reach $ 1.5 Billion by 2030 - InsightAce Analytic Pvt. Ltd.

Retrieved on: 
Wednesday, March 2, 2022
Investment, Multiple myeloma, Government, LLC, KCAS, Acquisition, HIV, Cell, Diagnosis, Flow cytometry, Leukemia, NeoGenomics, Awareness, Solution, Drug development, US, Company, Cancer, Lymphoma, Transport, Becton, Infection, Becton, Dickinson and Company headquarters, BD, Science, GraphPad Software, Efficiency, Laboratory, Research, LabArchives, Charles River Laboratories, Bio-Rad Laboratories, Data analysis, Protein, CAGR, Glossary of biology, AIDS, Antibody, Fine chemical, Medical imaging, Unilab, Fluorescence

According to the latest research by InsightAce Analytic, the global Flow Cytometry Services market is valued at US$ 876.33 Million in 2021, and it is expected to reach US$ 1,501.02 Million by 2030, with a CAGR of 6.21% during the forecast period of 2022-2030.

Key Points: 
  • According to the latest research by InsightAce Analytic, the global Flow Cytometry Services market is valued at US$ 876.33 Million in 2021, and it is expected to reach US$ 1,501.02 Million by 2030, with a CAGR of 6.21% during the forecast period of 2022-2030.
  • Flow cytometry is an effective laboratory technique used to analyze the cell population in heterogenous suspension based on their physical and fluorescence characteristics.
  • Flow Cytometry services consist of specimen processing, experimental design, acquisition and data analysis to strengthen biotech, pharmaceutical companies and researchers in drug development.
  • Curious about Report Details @ Request for ToC/Proposal: https://www.insightaceanalytic.com/report/global-flow-cytometry-services...
    Global Flow Cytometry Services Market, by Accreditation Types, 2019-2030 (Value US$ Mn)
    Global Flow Cytometry Services Market, by Services Types, 2019-2030 (Value US$ Mn)

Insightful Science Acquires Omiq to Add Cloud-Based Machine Learning to its Flow Cytometry Capabilities

Retrieved on: 
Thursday, January 13, 2022
Science, Software, Other Science, Research, Internet, Health, Technology, Other Health, Cloud, Biomarker, Flow cytometry, Research, Adaptive Insights, R, Algorithm, Insight Partners, Science, CEO, Solution, Health, GraphPad Software, Software as a service, LabArchives, Software, State observer, Compliance, Data analysis, GxP, Workflow, Organization, Partnership, Fine chemical, Management

Flow cytometry is a critical laboratory technology and scientific method used throughout the clinical R&D value chain.

Key Points: 
  • Flow cytometry is a critical laboratory technology and scientific method used throughout the clinical R&D value chain.
  • OMIQ provides impressive efficiencies to research organizations working with flow cytometry data through its novel combination of high-performance analytical power, centralized GxP compliant framework, and modern user-focused design.
  • OMIQ hosts a constantly evolving set of analytical functionalities that allow researchers to complete their entire workflow in one software, including cutting-edge machine learning algorithms and visualizations.
  • The addition of OMIQ expands Insightful Sciences offerings in flow cytometry software solutions including Cytapex Bioinformatics and FCS Express .

Protein Metrics Inc. Announces Eighth Straight Year of Record Growth

Retrieved on: 
Tuesday, January 11, 2022
Cloud, NQuery Sample Size Software, Technology, Adoption, Insight Partners, Growth, Science, CEO, GraphPad Software, Proteomics, Mass spectrometry, Dotmatics, LabArchives, Climate change, State observer, Organization, Fine chemical

CUPERTINO, Calif., Jan.11, 2022 /PRNewswire-PRWeb/ -- Protein Metrics Inc., the market leader in mass spectrometry software for protein characterization, announced today an eighth consecutive year of record growth in bookings and revenue.

Key Points: 
  • CUPERTINO, Calif., Jan.11, 2022 /PRNewswire-PRWeb/ -- Protein Metrics Inc., the market leader in mass spectrometry software for protein characterization, announced today an eighth consecutive year of record growth in bookings and revenue.
  • Protein Metrics has continued to work very closely with mass spectrometry vendors to enable the rapid adoption of new techniques and capabilities to our common customers.
  • The strong growth evidenced in 2021 provides a solid basis for Protein Metrics to help Insightful Science expand into protein characterization and proteomics in 2022.
  • "We continue to be impressed by the growth of Protein Metrics," said Thomas Swalla, CEO of Insightful Science.

Insightful Science Acquires LabArchives to Expand its Electronic Lab Notebook and LIMS Solutions for Scientific Discovery

Retrieved on: 
Wednesday, November 10, 2021
Data Management, Science, Other Science, Technology, Software, Cloud, State observer, Efficiency, Science, Entrepreneurship, CEO, Insight Partners, LabArchives, GraphPad Software, Data management, Growth, Research, Former, Solution, Fine chemical, Management

Insightful Science , the software company enabling the Cloud for Scientific Discovery, announced today that it has completed the transaction to acquire LabArchives .

Key Points: 
  • Insightful Science , the software company enabling the Cloud for Scientific Discovery, announced today that it has completed the transaction to acquire LabArchives .
  • Built as the central information hub in research labs, it automates data capture, enhances collaboration, creates seamless workflows, and improves lab efficiency.
  • Insightful Science is a growing portfolio of scientific research and data solutions, including GraphPad Prism, SnapGene, Geneious Prime, Dotmatics, and nQuery .
  • Earl Beutler, Co-Founder and Former Chairman of LabArchives, added: "I am proud that our team has joined a mission-driven company like Insightful Science.